Assessing the vaginal tablet - Misoprostol and Placebo(drug without any action) for dilatation of cervix before hysteroscopy(procedure where camera inserted into uterus through vagina to carry out small surgeries) using small size instrument-mini resectoscope
Not Applicable
- Conditions
- Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pre menopausal women and women with age >18 years scheduled for Operative hysteroscopic procedures with Mini resectoscope.
Exclusion Criteria
Known case of Cervical incompetence and stenosis
Contraindication to Misoprostol use like history of severe asthma, glaucoma, preexisting cardiac disease, hypertension or renal failure.
Significant uterovaginal prolapse precluding the administration of vaginal tablets.
Pelvic inflammatory disease.
Genital tract malignancy like Ca cervix, Vulval carcinoma.
Pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the pre- dilatation cervical width following vaginal Misoprostol Or vaginal Placebo instillation in women undergoing Operative hysteroscopy using a mini resectoscope-21FTimepoint: During Surgery
- Secondary Outcome Measures
Name Time Method To compare the need for further cervical dilatation, complications and side effects following vaginal Misoprostol Or vaginal Placebo instillation in women undergoing Operative hysteroscopy using a mini resectoscope-21FTimepoint: During surgery and 1 hour after surgery.